Serial analysis of circulating t gamma/delta lymphocyte subpopulations in graves' disease

References

• Bottazzo G F, Doniach D. Autoimmune thyorid disease. Ann Rev Med 1986; 37: 353–359
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Venutti D, Prigione I, Torre G C, Ferrini S, Canonica G W. Graves' dosease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid. Clin Immunopathol 1988; 47: 230–239
   PubMedGoogle Scholar
• Marazuela M, Postigo A A, Acevedo A, Diaz-González F, Sánchez-Madrid F, deLandazuri E. Adhesion molecules from the LFA-1/1CAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur J Immunol 1994; 24: 2483–2490
   PubMed Web of Science ®Google Scholar
• Mariotti S, del PG F, Mastrumauro C, De Carli M, Romagnani S, Ricci M, Pinchera A. The autoimmune infiltrate of Basedow's disease: analysis of clonal level and comparison with Hashimoto's thyroiditis. Exp Clin Endocrinol 1991; 97: 139–146
   PubMedGoogle Scholar
• Teng W P, Stark R, Munro A J, Young S M, Borysiewicz L K, Weetman A P. Peripheral blood T cell activation after radioiodine treatment for Graves' disease. Acta Endocrinol (Copenh) 1990; 122: 233–240
   PubMedGoogle Scholar
• Ohashi H, Okugawa T, Itoh M. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients. Acta Endocrinol (Copenh) 1991; 125: 502–509
   PubMedGoogle Scholar
• Teng W P, Cohen S B, Posnett D N, Weetman A P. T cell receptor phenotypes in autoimmune thyorid disease. J Endocrinol Invest 1990; 13: 339–342
   PubMed Web of Science ®Google Scholar
• Wilson R, Pearson C, McKillop J H, Burnett A K, Thompson J A. The behavior of suppressor-inducrer T cells following treatment for Graves' disease. Autoimmunity 1990; 6: 93–97
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Amino N, Hidaka Y, Kaneda T, Ichihara K, Tamaka H, et al. Decreases in alpha beta T cell receptor negative T cells and CD8 cells and an increase in CD4+CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clin Exp Immunol 1992; 87: 444–449
   PubMed Web of Science ®Google Scholar
• Afeltra A, Paggi A, Ferri G M, Amoroso A, DiPrima M A, Startari S, Faralli A R, Bonomo L. CD5+ B lymphocytes and CD4+CD45RA+ T cells in Graves'disease. Endocrine Res 1993; 19: 73–85
   PubMed Web of Science ®Google Scholar
• Roura I C, Alcalde L, Vargas F, Tolosa E, Obiols G, Foz M, Jaraquemada D, Pujol-Borrell R. Gamma delta lymphocytes in endocrine autoimmunity in Graves' disease but not in type i diabetes. Clin Exp Immunol 1993; 92: 288–295
   PubMed Web of Science ®Google Scholar
• Catalfamo M, Roura-Mir C, Sospedra M, Aparico P, Costagliola S, Ludgate M, Pujol-Borrell R, Jaraquemada D. Self-reactive cytoto γ δ lymphocytes in Graves's disease specifically recognize epithelial cells. J Immunol 1996; 156: 804–811
   PubMed Web of Science ®Google Scholar
• McIntosh R S, Tandon N, Pickerill A P, Davies R, Barnett D, Weetman A P. The γ δ T cell repertoire in Graves' disease and multinodular goitre. Clin Exp Immunol 1993; 94: 473
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Hidaka Y, Matsuzuka F, Kuma K, Amino N. Intrathyroial lymphocyte subsets, including unusual CD4+CD8+ cells and CD3IoTCR α βIo/CD4-CD8- cells, in autoimmune thyroid disease. Clin Exp Immunol 1993; 93: 430
   PubMed Web of Science ®Google Scholar
• Paolieri F, Pronzato C, Battifora M, Fiorino N, Canonica G W, Bagnasco M. Infiltrating γ δ T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis Graves' disease and papillary thyroid cancer. J Endocrinol Invest 1995; 18: 295–298
   PubMed Web of Science ®Google Scholar
• Corrales J J, Orfao A, López A, Ciudad J, Mories M T. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves'disease. J Endocrinol 1996; 151: 231–240
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, et al. Marked increase of CD5+B cells in hyperthyroid Graves' disease. Clin Exp Immunol 1989; 78: 196–200
   PubMed Web of Science ®Google Scholar
• Matis A L, Fry A M, Cron R Q, Cotterman R R, Cotterman M M, Dick R F, Bluestone J A. Structure and specificity of a class II MHC alloreactive gamma/delta T cell receptor heterodimer. Science 1989; 245: 746–749
   PubMed Web of Science ®Google Scholar
• Moretta L, Ciccone E, Ferrini S, et al. Molecular and cellular analysis of human T lymphocytes expressing γ δ T-cell receptor. Immunol Rev 1991; 100: 117–126
   Google Scholar
• Doherty P J, Yang S X, Laxer R K, Silverman E D, Inrnan R, Pan S. Evidence for clonal expansion of T cell receptor VII+ T cells in the sinovial fluid of patients with arthritis. J Immunol 1992; 149: 295
   PubMed Web of Science ®Google Scholar
• Larsen P R, Ingbar S H. The thyroid gland. Williams Textbook of Endocrinology, J D Wilson, D W Foster. WB Saunders, Philadelphia 1992; pp. 356–487
   Google Scholar
• Laso F J, Madruga J I, Girón J A, López A, Ciudad J, SanMiguel J F, et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997; 25: 1096–1100
   PubMed Web of Science ®Google Scholar
• Weetman A P, McGregor A M. Autoimmune thyroid disease: developments in our understanding. Endocrine Rev 1994; 15: 309–355
   Web of Science ®Google Scholar
• Totterman T H, Karlsson F A, Bengtsson M, Mendel-Hartvig I. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. N Engl J Med 1987; 316: 15–22
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Iitaka V, Row V, Volpé R. Induction of thyroid autoantibody production: Synergistic effect of B cell mitogen combined with T cell mitogen. J Clin Endocrinol Metab 1987; 65: 853–861
   PubMed Web of Science ®Google Scholar